Cargando…
How do mTOR inhibitors fit in the landscape of treatment for relapsed acute lymphoblastic leukemia?
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Fondazione Ferrata Storti
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521218/ https://www.ncbi.nlm.nih.gov/pubmed/35112555 http://dx.doi.org/10.3324/haematol.2021.280395 |
| _version_ | 1784799793990598656 |
|---|---|
| author | Pinchinat, Ashley Raetz, Elizabeth |
| author_facet | Pinchinat, Ashley Raetz, Elizabeth |
| author_sort | Pinchinat, Ashley |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9521218 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Fondazione Ferrata Storti |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-95212182022-10-24 How do mTOR inhibitors fit in the landscape of treatment for relapsed acute lymphoblastic leukemia? Pinchinat, Ashley Raetz, Elizabeth Haematologica Editorial Fondazione Ferrata Storti 2022-02-03 /pmc/articles/PMC9521218/ /pubmed/35112555 http://dx.doi.org/10.3324/haematol.2021.280395 Text en Copyright© 2022 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
| spellingShingle | Editorial Pinchinat, Ashley Raetz, Elizabeth How do mTOR inhibitors fit in the landscape of treatment for relapsed acute lymphoblastic leukemia? |
| title | How do mTOR inhibitors fit in the landscape of treatment for relapsed acute lymphoblastic leukemia? |
| title_full | How do mTOR inhibitors fit in the landscape of treatment for relapsed acute lymphoblastic leukemia? |
| title_fullStr | How do mTOR inhibitors fit in the landscape of treatment for relapsed acute lymphoblastic leukemia? |
| title_full_unstemmed | How do mTOR inhibitors fit in the landscape of treatment for relapsed acute lymphoblastic leukemia? |
| title_short | How do mTOR inhibitors fit in the landscape of treatment for relapsed acute lymphoblastic leukemia? |
| title_sort | how do mtor inhibitors fit in the landscape of treatment for relapsed acute lymphoblastic leukemia? |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521218/ https://www.ncbi.nlm.nih.gov/pubmed/35112555 http://dx.doi.org/10.3324/haematol.2021.280395 |
| work_keys_str_mv | AT pinchinatashley howdomtorinhibitorsfitinthelandscapeoftreatmentforrelapsedacutelymphoblasticleukemia AT raetzelizabeth howdomtorinhibitorsfitinthelandscapeoftreatmentforrelapsedacutelymphoblasticleukemia |